The Power of Nurses: Celebrating International Nurses Day
Think about a time you or a loved one were in a vulnerable position, navigating the complexities of illness or injury. Who was there, not only...
1 min read
Brittney Nelson, BSN, RN, SCRN
:
Feb 25, 2019
Target: Stroke, launched in 2010 by the American Heart Association, was a quality improvement initiative aimed at helping stroke centers reduce their door-to-needle treatment times.
At the 2019 International Stroke Conference, the AHA released phase III, which will give facilities the ability to be recognized for their efforts of faster door-to-needle times while also giving first-ever goals for Endovascular Treatment. Facilities who meet the new Phase III requirements will have the ability to be recognized starting in 2020.
Does your facility have a plan for meeting the new phase III goals?
If not, Pulsara should be your answer! Did you know the #1 reason for delayed treatment is communication breakdown? At Pulsara, we pride ourselves on our ability to place entire teams on the same communication channel - which research shows decreases treatment times and can help reduce medical errors secondary to miscommunication.
For more information on Target: Stroke Phase III click HERE
To find out how Pulsara can help YOU decrease treatment times at your facility and get you one step closer to meeting Target: Stroke Phase III Goals click HEREThink about a time you or a loved one were in a vulnerable position, navigating the complexities of illness or injury. Who was there, not only...
April Recap Optimize Patient Transfer WorkflowsOur newest package, Pulsara TRANSFER OPS, empowers teams to streamline communication within and across...
Leverage Existing Pulsara Capabilities for Streamlined Patient Movement Efficient patient transfers are the lifeblood of a well-functioning...